Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: A cost-effectiveness analysis☆

Spiegel, Brennan; DeRosa, Vincent; Gralnek, Ian M.; Wang, Victor; Dulai, Gareth S.

doi:10.1053/j.gastro.2004.03.012

Cited by 121 publications

(85 citation statements)

References 39 publications

(58 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several studies have shown that testing for CD in patients with IBS-type symptoms is likely to be cost-effective (20)(21)(22). Spiegel et al reported that histological testing for CD had an acceptable cost when CD prevalence was more than 1%, and became the dominant strategy, cheaper than empirical symptom-based therapy for presumed IBS, when the prevalence reached 8% (21).…”

Section: Discussionmentioning

confidence: 99%

“…Spiegel et al reported that histological testing for CD had an acceptable cost when CD prevalence was more than 1%, and became the dominant strategy, cheaper than empirical symptom-based therapy for presumed IBS, when the prevalence reached 8% (21). Another study reported that at a CD prevalence of 3% there was only a 1% increase in lifetime costs of managing IBS with tTG testing for CD, with the cost per quality adjusted life year falling to $4900 if the prevalence of CD in IBS was assumed to be 5% (20), close to the upper confidence limit of the estimate from our meta-analysis.…”

Section: Discussionmentioning

confidence: 99%

“…Economic modeling studies have suggested that excluding CD in patients with symptoms compatible with IBS could be cost-effective (20)(21)(22). Partly as a result of these studies, current guidelines for the management of CD recommend opportunistic screening of patients with IBS-type symptoms for CD, via serological testing (23, 24).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis

Irvine

Chey

Ford

2017

American Journal of Gastroenterology

122

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis

Irvine

Chey

Ford

2017

American Journal of Gastroenterology

122

View full text Add to dashboard Cite

“…96 These figures are comparable to the study by Mein and Ladabaum, 97 who found a prevalence of coeliac disease in irritable bowel syndrome of 3%, and concluded that testing for coeliac disease in patients with suspected IBS is likely to be costeffective. In another recent study, Spiegel and colleagues 98 found that testing for coeliac disease was likely to be cost-effective at a prevalence above 1%.…”

Section: Discussionmentioning

confidence: 99%

Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial

Kennedy¹,

Chalder²,

McCrone³

et al. 2006

Health Technol Assess

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email.Paying by official purchase order You can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK.We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NHS R&D HTA ProgrammeT he research findings from the NHS R&D Health Technology Assessment (HTA) Programme directly influence key decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC) who rely on HTA outputs to help raise standards of care. HTA findings also help to improve the quality of the service in the NHS indirectly in that they form a key component of the 'National Knowledge Service' that is being developed to improve the evidence of clinical practice throughout the NHS.The HTA Programme was set up in 1993. Its role is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care.The HTA Programme commissions research only on topics where it has identified key gaps in the evidence needed by the NHS. Suggestions for topics are actively sought from people working in the NHS, the public, service-users groups and professional bodies such as Royal Colleges and NHS Trusts.Research suggestions are carefully considered by panels of independent experts (including service users) whose advice results in a ranked list of recommended research priorities. The HTA Programme then commissions the research team best suited to und...

show abstract

“…Según este Consenso, el escrutinio diagnóstico debe limitarse a ciertas pruebas de laboratorio (Tabla 1) y se debe realizar colonoscopia ante signos de alarma (pérdida de peso, hemorragia, anemia, fiebre, historia familiar de cáncer de colon o enfermedad inflamatoria intestinal), inicio de síntomas >50 años o cambio en el patrón de los síntomas 10 . Sólo se recomienda evaluación para enfermedad celíaca en regiones con una prevalencia mayor a 1% 11 .…”

Section: N V E S T I G a C I ó Nunclassified

El escrutinio diagnóstico limitado puede disminuir el impacto económico directo del síndrome de intestino irritable (SII)

Schmulson¹

2008

Rev. méd. Chile

View full text Add to dashboard Cite

Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: A cost-effectiveness analysis☆

Cited by 121 publications

References 39 publications

Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis

Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis

Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial

El escrutinio diagnóstico limitado puede disminuir el impacto económico directo del síndrome de intestino irritable (SII)

Contact Info

Product

Resources

About